Xilio Therapeutics (XLO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

It's not exactly a compliment.

Is G2 Esports' run at First Stand a sign that the gab is closing between the Western and Eastern teams? Maybe not yet.

Supreme Court justices had pointed questions for both sides during oral arguments on President Donald Trump's birthright ...

Get live updates and the latest news as the Supreme Court weighs Trump's effort to limit birthright citizenship and the ...

The stock could plunge in a bear market due to its sky-high valuation, but otherwise, Palantir continues to look like a ...

President Trump is challenging the longstanding interpretation of a constitutional provision guaranteeing birthright ...

For the US to reach a deal or end its war with Iran, President Trump has said he wants the country to surrender its “enriched ...

At issue is President Trump's challenge to a constitutional provision that has long been interpreted to guarantee American ...

The Supreme Court hears oral arguments over President Donald Trump's proposal to limit birthright citizenship for people born ...

Who’s behind it: Councilmember Traci Park, who represents the Pacific Palisades, has introduced a motion to explore waiving ...